A carregar...

Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit?

Acute myeloid leukemia (AML) is a clinically and genetically heterogenous malignancy of myeloid progenitor cells that affects patients of all ages. Despite decades of research and improvement in overall outcomes, standard therapy remains ineffective for certain subtypes of AML. Current treatment is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Wojcicki, Anna V., Kadapakkam, Meena, Frymoyer, Adam, Lacayo, Norman, Chae, Hee-Don, Sakamoto, Kathleen M.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7072462/
https://ncbi.nlm.nih.gov/pubmed/32069925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12020441
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!